Freeline Therapeutics Holdings plc

Informe acción NasdaqCM:FRLN

Capitalización de mercado: US$28.3m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Salud financiera de hoja de balance de Freeline Therapeutics Holdings

Salud financiera controles de criterios 4/6

Freeline Therapeutics Holdings tiene un patrimonio de los accionistas total de $30.0M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $49.2M y $19.2M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$29.45m
PatrimonioUS$30.04m
Total pasivoUS$19.18m
Activos totalesUS$49.22m

Actualizaciones recientes sobre salud financiera

Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Apr 11
Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Dec 20
Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Recent updates

Calculating The Intrinsic Value Of Freeline Therapeutics Holdings plc (NASDAQ:FRLN)

Jul 13
Calculating The Intrinsic Value Of Freeline Therapeutics Holdings plc (NASDAQ:FRLN)

Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Apr 11
Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

Dec 20
Here's Why Freeline Therapeutics Holdings (NASDAQ:FRLN) Must Use Its Cash Wisely

We're Keeping An Eye On Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn Rate

Aug 30
We're Keeping An Eye On Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn Rate

Freeline gains as NEJM publishes long-term data for hemophilia therapy

Jul 21

Is Freeline Therapeutics Holdings (NASDAQ:FRLN) In A Good Position To Invest In Growth?

May 05
Is Freeline Therapeutics Holdings (NASDAQ:FRLN) In A Good Position To Invest In Growth?

Will Freeline Therapeutics Holdings (NASDAQ:FRLN) Spend Its Cash Wisely?

Jan 13
Will Freeline Therapeutics Holdings (NASDAQ:FRLN) Spend Its Cash Wisely?

Companies Like Freeline Therapeutics Holdings (NASDAQ:FRLN) Could Be Quite Risky

Sep 30
Companies Like Freeline Therapeutics Holdings (NASDAQ:FRLN) Could Be Quite Risky

Here's Why We're Watching Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn Situation

Jun 03
Here's Why We're Watching Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn Situation

What Kind Of Shareholders Hold The Majority In Freeline Therapeutics Holdings plc's (NASDAQ:FRLN) Shares?

Feb 18
What Kind Of Shareholders Hold The Majority In Freeline Therapeutics Holdings plc's (NASDAQ:FRLN) Shares?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($34.0M) de FRLN superan a sus pasivos a corto plazo ($17.5M).

Pasivo a largo plazo: Los activos a corto plazo de FRLN ($34.0M) superan a sus pasivos a largo plazo ($1.7M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: FRLN está libre de deudas.

Reducción de la deuda: FRLN no ha tenido ninguna deuda en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: FRLN tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: Datos insuficientes para determinar si FRLN tiene suficiente cash runway en caso de que su flujo de caja libre siga creciendo o disminuyendo basado en tasas históricas.


Descubre empresas con salud financiera